Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by carduon Dec 16, 2010 4:52pm

345 Views

Post# 17858539

Manipulation today!

It started at the open on 500 shares and ended at the close with the ubiquitous 100 share trade. One day, I hope, they will be burned by suddenly leaked positive news. However, as we all know, the retail investor is the proverbial sheep standing around passively waiting to be sheared.

When ONC reaches it's zenith I'm out of investing for good and will enjoy my time in the sun spending the proceeds.Up to now I haven't needed to go to Florida to get burned, I got tanned by the "market".

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill